Monday October 22, 2018

Introducing Yoga at Minnesota: Hindus praise the practice in the State Fair

Yoga can be very effective in developing coping skills and reaching a more positive outlook on life

1
//
342
Republish
Reprint
  • The Fair is one of the largest expositions in the world, first held in 1859, and has initiated the “Great Yoga Get-Together at Carousel Park”
  • Zed, President of the Universal Society of Hinduism, has also called yoga “a living fossil” in a statement in Nevada and said that it is a discipline, both mental and physical, for everyone to share
  • Yoga has been scientifically proven to be relaxing and a stress-eliminator. It also aids in gaining flexibility, improved posture, and better breathing

Hindus in Nevada have praised the Minnesota State Fair for introducing yoga on August 25, in 2016 event. The Fair is one of the largest expositions in the world, first held in 1859, and has initiated the “Great Yoga Get-Together at Carousel Park”.

The demonstration will encourage the attendees of the fair to “stop by to try different styles of yoga” with skilled instructors in a plethora of classes. It will also include activities, prize drawings, and even information about the benefits of yoga.

According to punjabnewsexpress.com, Hindu statesman, Rajan Zed, has commended the act and said it is a “step towards positive direction”. He also questioned the delay in appreciating the many benefits yoga offers and encouraged all US state fairs to launch similar practices. He said, it will be a movement towards the positive and provide all the fair attendees to discover and incorporate “the unique treasure” into their lives.

Crowd at Minnesota State Fair 2012. Image source: By Anndelion on Wikimedia Commons
The crowd at Minnesota State Fair 2010. Image source: By Anndelion on Wikimedia Commons

Zed, President of the Universal Society of Hinduism also called yoga “a living fossil” in a statement in Nevada and said that it is a discipline, both mental and physical, for everyone to share. It was, he said, introduced and developed by Hinduism, but is now a heritage for everybody and a “liberation powerhouse to be utilized by all”.

Follow NewsGram on Twitter

Yoga has been scientifically proven to be relaxing and a eliminate stress. It also aids in gaining flexibility, improved posture, and better breathing. A 2016 Yoga in America Study has stated that practicing yoga also improves self-image. It also indicated how popular yoga is becoming amongst Americans with 37 million people and celebrities having taken it up already, mentioned punjabnewsexpress.com.

The American Osteopathic Association has also listed the other used as: increased muscle strength and tone, improved energy and vitality, maintaining a balanced metabolism, weight reduction, cardio and circulatory health, improved athletic performance, and protection from injury. It also states how yoga relieves stress, and in turn relieves the various physical effects stress can have on the body, for instance, back and neck pain, sleeping problems, headaches, drug abuse, and an inability to concentrate.

Follow NewsGram on Facebook

Dr. Natalie Nevins, DO, a board-certified osteopathic family physician as well as a certified Kundalini Yoga instructor in Hollywood, has said, “Yoga can be very effective in developing coping skills and reaching a more positive outlook on life. Whether you’re a couch potato or a professional athlete, size and fitness levels do not matter because there are modifications for every yoga pose and beginner classes in every style. The idea is to explore your limits, not strive for some pretzel-like perfection. It is a great way to get in tune with your body and your inner self.”

– prepared by Varsha Gupta of NewsGram. Twitter: @VarshaGupta94

ALSO READ:

Click here for reuse options!
Copyright 2016 NewsGram

  • Akanksha Sharma

    Yoga helps in maintaining a balanced metabolism and prevent many diseases

Next Story

Immunotherapy Drugs Show Significant Improvement Against Breast Cancer: Study

Side effects need a close look, both doctors said. Nearly all study participants had typical chemo side effects such as nausea or low blood cell counts.

0
Breast Cancer
This undated fluorescence-colored microscope image made available by the National Institutes of Health in September 2016 shows a culture of human breast cancer cells. For the first time, one of the new immunotherapy drugs has shown promise against breast cancer in a large study that combined it with chemotherapy to treat an aggressive form of the disease. VOA

For the first time, one of the new immunotherapy drugs has shown promise against breast cancer in a large study that combined it with chemotherapy to treat an aggressive form of the disease. But the benefit for most women was small, raising questions about whether the treatment is worth its high cost and side effects.

Results were discussed Saturday at a cancer conference in Munich and published by the New England Journal of Medicine.

Drugs called checkpoint inhibitors have transformed treatment of many types of cancer by removing a chemical brake that keeps the immune system from killing tumor cells. Their discovery recently earned scientists a Nobel Prize. Until now, though, they haven’t proved valuable against breast cancer.

Breast Cancer
Weight loss may lower breast cancer risk for post-menopausal women. Pixabay

In the study

The new study tested one from Roche called Tecentriq plus chemo versus chemo alone in 902 women with advanced triple-negative breast cancer. About 15 percent of cases are this type, their growth is not fueled by the hormones estrogen or progesterone, or the gene that Herceptin targets, making them hard to treat.

Women in the study who received Tecentriq plus chemo went two months longer on average without their cancer worsening compared with those on chemo alone, a modest benefit. The combo did not significantly improve survival in an early look before long-term follow-up is complete.

Failed protein test

Previous studies found that immunotherapies work best in patients with high levels of a protein that the drugs target, and the plan for the breast cancer study called for analyzing how women fared according to that factor if Tecentriq improved survival overall.

breast cancer
FILE – A patient receives chemotherapy treatment for breast cancer at the Antoine-Lacassagne Cancer Center in Nice, July 26, 2012. VOA

The drug failed that test, but researchers still looked at protein-level results and saw encouraging signs. Women with high levels who received the combo treatment lived roughly 25 months on average versus about 15 months for women given chemo alone.

That’s a big difference, but it will take more time to see if there’s a reliable way to predict benefit, said Dr. Jennifer Litton of the MD Anderson Cancer Center in Houston. She had no role in running the study but enrolled some patients in it and oversees 14 others testing immunotherapies.

“We’re really hopeful that we can identify a group of women who can get a much bigger and longer response,” she said.

Another breast cancer specialist with no role in the study, Dr. Michael Hassett at Dana-Farber Cancer Institute in Boston, said he felt “cautious excitement” that immunotherapy may prove helpful for certain breast cancer patients.

Breast Cancer
Breast cancer cell, Wikimedia Commons

Side effects and cost

Side effects need a close look, both doctors said. Nearly all study participants had typical chemo side effects such as nausea or low blood cell counts, but serious ones were more common with the combo treatment and twice as many women on it stopped treatment for that reason.

Three of the six deaths from side effects in the combo group were blamed on the treatment itself; only one of three such deaths in the chemo group was.

Also Read: New DNA Tool To Predict People’s Height And Risk For Cancer

Cost is another concern. Tecentriq is $12,500 a month. The chemo in this study was Celgene’s Abraxane, which costs about $3,000 per dose plus doctor fees for the IV treatments. Older chemo drugs cost less but require patients to use a steroid to prevent allergic reactions that might interfere with the immunotherapy. Abraxane was chosen because it avoids the need for a steroid, said one study leader, Dr. Sylvia Adams of NYU Langone Health.

The study was sponsored by Roche and many study leaders consult or work for the company or own stock in it. (VOA)